Photodynamic therapy with HiPorfin for cervical squamous intraepithelial lesion at childbearing age

Yu Liu,Ruifang Wu,Changzhong Li,Lihui Wei,Ruizhen Li
DOI: https://doi.org/10.1016/j.pdpdt.2024.104018
IF: 3.577
2024-02-25
Photodiagnosis and Photodynamic Therapy
Abstract:Objective To evaluate the clinical efficacy and safety of HiPorfin® photodynamic therapy (PDT) in the treatment of young women at reproductive age with high-grade squamous intraepithelial lesion (HSIL) of the cervix. Methods Prospective study of 41 patients aged 28.8±4.6 years old with cervical intraepithelial neoplasia (CIN) II-III at Peking University Shenzhen Hospital from March 2019 to January 2023. HiPorfin® (2mg/kg) was infused intravenously, and 48-72h later, 630-nm laser irradiation was performed in cervical canal and cervical surface with an irradiation dose of 100-120J/cm 2 and 150J/cm 2 respectively. Results All 41 patients with no recurrence had been observed at least 12 months follow-up period after PDT. The number of nulliparous women was 30 (30/41, 73.2%). CIN II were 22 cases (22/41,53.7%) and CIN III were 19 cases (19/41,46.3%). Complete response (CR) was in 95.5% (21/22) patients with CIN II and 78.9% (15/19) patients with CIN III at 6 months follow-up. Meanwhile, CR rate was 100.0% (22/22) and 84.2% (16/19) in CIN II and CIN III group respectively at 12 months. Pre-treatment, all patients (41/41,100%) were Human papilloma virus (HPV) positive. HPV eradication rate was 63.4% (26/41), 73.2% (30/41) and 92.7% (38/41) at 3, 6 and 12 months after PDT respectively. Before treatment, cytology ≥ atypical squamous cells of undetermined significance (ASCUS) was 78.0% (32/41). Negative conversion ratio of cytology was 75.0% (24/32), 90.6% (29/32) and 100.0% (32/32) at 3, 6 and 12 months after PDT respectively. There were no serious adverse effects in patients during and after PDT. Conclusion HiPorfin-PDT is a promising and organ-saving approach for cervical HSIL, which also eradicates HPV infection effectively and can be a beacon of hope for the young women with fertility preservation requirement.
oncology
What problem does this paper attempt to address?